[{"address1": "149 Fifth Avenue", "address2": "Suite 500", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 994 8200", "website": "https://www.protagenic.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Dr. Garo H. Armen Ph.D.", "age": 70, "title": "Co-Founder & Executive Chairman of the Board", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexander Kenneth Arrow C.F.A., M.D.", "age": 52, "title": "CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Slee Ph.D.", "age": 73, "title": "Chief Operating Officer", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Benjamin Stein M.D., Ph.D.", "age": 72, "title": "Chief Medical Officer & Director", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.3, "open": 1.34, "dayLow": 1.28, "dayHigh": 1.34, "regularMarketPreviousClose": 1.3, "regularMarketOpen": 1.34, "regularMarketDayLow": 1.28, "regularMarketDayHigh": 1.34, "beta": 0.383, "forwardPE": -2.2068965, "volume": 1751, "regularMarketVolume": 1751, "averageVolume": 12006, "averageVolume10days": 12830, "averageDailyVolume10Day": 12830, "marketCap": 5676966, "fiftyTwoWeekLow": 0.68, "fiftyTwoWeekHigh": 2.32, "fiftyDayAverage": 1.34226, "twoHundredDayAverage": 1.266865, "currency": "USD", "enterpriseValue": 1620957, "floatShares": 3217910, "sharesOutstanding": 4435130, "sharesShort": 9829, "sharesShortPriorMonth": 12224, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0022, "heldPercentInsiders": 0.21831, "heldPercentInstitutions": 0.079629995, "shortRatio": 0.65, "shortPercentOfFloat": 0.0027, "bookValue": 0.827, "priceToBook": 1.5477629, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -5000497, "trailingEps": -1.15, "forwardEps": -0.58, "enterpriseToEbitda": -0.36, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PTIX", "underlyingSymbol": "PTIX", "shortName": "Protagenic Therapeutics, Inc.", "longName": "Protagenic Therapeutics, Inc.", "firstTradeDateEpochUtc": 1619530200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c39eb2ce-38b5-3b80-82ab-59608762cc06", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.28, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 4056012, "totalCashPerShare": 0.915, "ebitda": -4498756, "quickRatio": 6.19, "currentRatio": 6.41, "returnOnAssets": -0.4578, "returnOnEquity": -0.94477, "freeCashflow": -2473085, "operatingCashflow": -3703776, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]